Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 815 results for "eli lilly"

Eli Lilly Shares Climbing Higher, Up 2.4%

Eli Lilly (NYSE:LLY) is one of today's biggest movers, up 2.4% to $65.90. The S&P is trading higher by 0.4% to 1,958 and the Dow is trading 0.5% higher Individual.com, 1 day ago

63 images for eli lilly

American Banking News, 1 day ago
RTTNews.com, 2 days ago
BioSpace, 2 days ago
Dividend.com, 2 days ago
BioSpace, 2 days ago
BioSpace, 2 days ago
Pharma Letter, 1 day ago
I Stock Analyst, 3 days ago
Jutia Group, 3 days ago
Yahoo! Finance, 1 week ago

Eli Lilly (LLY) Breaks Through Resistance at $65.11

Shares of Eli Lilly (NYSE:LLY) opened today above their pivot of $64.44 and have already reached the first level of resistance at $65.11. Should the shares continue to rise, the resistance pivots of $65.86 and $67.28 will be
 Individual.com1 day ago

ModernGraham Quarterly Valuation Of Eli Lilly & Co.

Summary LLY is suitable for Enterprising Investors following the ModernGraham approach. According to the ModernGraham valuation model, the company is fairly valued at the present time. The market is implying 4.85% earnings growth over the next ...
 Seeking Alpha1 day ago
Dividend.com

Eli Lilly and's (LLY) CEO John Lechleiter on Q3 2014 Results - Earnings Call Transcript

Operator Ladies and gentlemen, thank you for standing by and welcome to the Third Quarter Financial Review. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the conference over to our host, Chairman, ...
 Seeking Alpha2 days ago Patent expirations hit Eli Lilly 3Q profit  Yahoo! UK and Ireland2 days ago Eli Lilly Hit By Patent Expirations, Prescription Volume Plunges  TheStreet.com2 days ago Eli Lilly's Sales Hit Again by Patent Expirations  Austin American Statesman2 days ago
[x]  
CNBC

Cheaper Generics Take Toll, Lilly Profit Plunges

Eli Lilly and Co ( LLY ) said its quarterly earnings plunged 58 percent, hurt by special charges and generic competition for its Cymbalta depression drug, but it affirmed its earlier full-year profit forecast. The U.S. drugmaker on Thursday said ...
 FOXBusiness.com2 days ago Eli Lilly profits fall as generics hurt  Ireland Business World2 days ago Lilly profit sinks as generics take toll  CNBC2 days ago Lilly profit plunges as cheaper generics take toll  CNBC2 days ago
[x]  
American Banking News

Eli Lilly Narrows Revenue Guidance

Eli Lilly & Co. (NYSE: LLY) said it continues to expect 2014 earnings of $2.72 to $2.80 per share but now expects revenue of $19.40 billion to $19.80 billion. The company's previous guidance was revenue of $19.40 billion to $20.00 billion and the ...
 Individual.com2 days ago Eli Lilly and (LLY) Releases Quarterly Earnings, Misses Expectations By $0.01 EPS  American Banking News2 days ago Eli Lilly's Q3 Earnings Preview  Bidness Etc3 days ago Eli Lilly's Q3 Earnings In-Line but Generics Hit Revenues  Yahoo! Finance1 day ago
[x]  

Lilly Misses Estimates as Drug Patent Expirations Cut Revenue

Oct. 23 (Bloomberg) -- Eli Lilly & Co. missed analyst earnings estimates as revenue from its top drugs plummeted in what the company has said will be its worst year of sales. Third-quarter net income fell 58 percent to $501 million, or 47 cents a ...
 La Repubblica2 days ago Lilly Misses Estimates as Patent Expirations Cut Sales  Bloomberg2 days ago
[x]  

Boehringer and Lilly receive FDA acceptance for NDA of type 2 diabetes drug

Boehringer Ingelheim and Eli Lilly and Company have received the FDA acceptance for new drug application, or NDA, of empagliflozin plus immediate-release metformin hydrochloride fixed-dose combination, an investigational compound being studied for ...
 Individual.com2 days ago FDA Accepts Lilly's NDA Filing For Empagliflozin/metformin Combination  RTTNews.com4 days ago Lilly Diabetes Treatment Moves Forward  Inside INdiana Business4 days ago Eli Lilly : U.S. Food and Drug Administration accepts filing of new drug application for empagliflozin/metformin fixed-dose combination  4 Traders4 days ago
[x]  
American Banking News

Eli Lilly declares $0.49 dividend

16:22 ET | About: Eli Lilly and Company (LLY) Eli Lilly (NYSE:LLY) declares $0.49/share quarterly dividend, in line with previous. Forward yield 3.11% Payable Dec. 10; for shareholders of record Nov. 14; ex-div Nov. 12. Sent to 10,013 ...
 Seeking Alpha5 days ago Eli Lilly and Co Plans Quarterly Dividend of $0.49 (LLY)  American Banking News5 days ago ELI LILLY : Lilly Declares Fourth-Quarter 2014 Dividend  4 Traders5 days ago Lilly's board to pay dividend to holders of record of 14 November 2014  Individual.com4 days ago
[x]  
Pharma Letter

Lilly, Zymeworks expand collaboration agreement

News and views on the clinical trials industry Friday, October 24, 2014 01:10 PM Eli Lilly and Zymeworks , a Vancouver-based, privately held biotherapeutics company, are expanding an existing licensing and collaboration agreement. Originally ...
 Center Watch1 day ago Zymeworks, Lilly extend deal for new bi-specific immunotherapies on Azymetric platform  Pharmaceutical Business Review1 day ago Eli Lilly adds $375M to Zymeworks partnership  Yahoo! UK and Ireland3 days ago Lilly expands collaboration with Zymeworks  Pharma Letter2 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less